Thyroid C-cell Tumors: In rodent research, semaglutide continues to be revealed to lead to thyroid C-cell tumors. It truly is mysterious irrespective of whether this risk applies to humans, but semaglutide is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or clients with Numerous Endocrine Neoplasia